FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/05/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
MAKING PROTEINS ACCESSIBLE
ST13
US500000079377404Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Rebecca Liebowitz Venable LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations for scientific purposes; chemical preparations, enzymes, gene editing enzymes, oligonucleotides, and proteins for scientific and industrial purposes; genes, DNA and RNA being nucleic acid sequences for scientific and industrial purposes; nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA, synthetic RNA and synthetic genes being nucleic acid sequences for scientific and industrial purposes; synthetic oligonucleotides and synthetic proteins for scientific and industrial use; chemicals, reagents and enzymes for use in the preparation and creation of synthetic DNA, synthetic RNA, synthetic genes being nucleic acid sequences for scientific and industrial purposes; molecular biology research tools in the nature of biological and biochemical reagents; molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, oligonucleotides, genes and proteins for scientific and industrial purposes
Classe 5
Biological, chemical and biochemical reagents, namely, proteins, and gene editing enzymes, all for medical diagnostic use; synthetic proteins for medical diagnostic use; vaccines
Classe 9
Scientific laboratory apparatus and instruments, namely, scientific desktop instruments for DNA, RNA, gene and protein synthesis for scientific use; scientific desktop instruments for DNA, RNA, gene and protein synthesis, namely, microfluidic devices; cartridges containing biological samples for use in scientific apparatus in connection with DNA, RNA, gene, cell and protein synthesis and characterization instruments, namely microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors in the nature of sensor chips for scientific, research or industrial purposes in DNA, RNA, gene and protein synthesis; biochips in the nature of microchips; scientific research and laboratory apparatus, namely, apparatus and instruments for amplifying DNA and RNA, namely, reactors, bioreactors, and laboratory apparatus and instruments for amplifying DNA and RNA using thermocyclers, not for medical purposes; apparatus and instruments for synthesising DNA and RNA, namely, microarrays, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips, not for medical purposes; scientific research and laboratory apparatus, namely, apparatus and instruments for processing DNA and RNA, namely scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, biosensors, and biochips; computer hardware; recorded computer software, downloadable computer software and downloadable bioinformatics software for use in DNA, RNA, gene and protein synthesis in the fields of biotechnology, drug discovery and medical science
Classe 10
Medical apparatus and instruments used for DNA and RNA testing and analysis and genetic testing, all for medical purposes; apparatus and instruments for DNA and RNA analysis, DNA and RNA sequencing and protein synthesis in the nature of microfluidic chips, microfluidic cartridges, micro-electromechanical chips, bio sensors, and bio-chips for medical and veterinary purposes; apparatus for DNA, RNA, gene and protein synthesis in the nature of microfluidic chips, microfluidic cartridges, micro-electromechanical chips, bio sensors, and bio-chips for medical and veterinary purposes
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FINAL DECISION TRANSACTION PROCESSED BY IB
24/05/2025
FINAL DISPOSITION NOTICE SENT TO IB
05/05/2025
FINAL DISPOSITION PROCESSED
05/05/2025
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/03/2025
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2025
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/03/2025
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2025
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2025
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
15/02/2025
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/01/2025
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
26/01/2025
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/12/2024
REGISTERED-PRINCIPAL REGISTER
03/12/2024
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2024
PUBLISHED FOR OPPOSITION
01/10/2024
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
23/08/2024
EXAMINER'S AMENDMENT ENTERED
09/08/2024
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/08/2024
EXAMINERS AMENDMENT E-MAILED
09/08/2024
EXAMINERS AMENDMENT -WRITTEN
09/08/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/07/2024
REFUSAL PROCESSED BY IB
02/04/2024
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/03/2024
REFUSAL PROCESSED BY MPU
11/03/2024
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/02/2024
NON-FINAL ACTION WRITTEN
10/02/2024
ASSIGNED TO EXAMINER
05/02/2024
APPLICATION FILING RECEIPT MAILED
05/09/2023
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2023
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/08/2023
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.